Ron Piervincenzi has been named chief executive officer of the United States Pharmacopeial Convention (USP) and chairman of the Council of Experts, USP's standards-setting body.


United States Pharmacopeial Convention, USP, Ron Piervincenzi, chief executive officer, CEO, Roger Williams, Council of Experts, McKinsey & Co., Thomas Temple, Timothy Franson, global standards for pharmaceuticals


















































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Retail News Breaks Archives

USP appoints Piervincenzi as CEO

January 8th, 2014

ROCKVILLE, Md. – Ron Piervincenzi has been named chief executive officer of the United States Pharmacopeial Convention (USP) and chairman of the Council of Experts, USP's standards-setting body.

Ron Piervincenzi

USP said Wednesday that Piervincenzi, who takes the reins from outgoing CEO Roger Williams, is slated to assume his new responsibilities on Feb. 1.

"I am excited and honored to lead USP's mission to improve global health," Piervincenzi said in a statement. "This is an outstanding organization, doing life-changing work around the world, and I look forward to focusing the collective energy, expertise and knowledge of USP's global volunteers and staff on the challenges of the future."

Piervincenzi was a partner and leader in McKinsey & Co.'s global pharmaceutical and medical products practice for 12 years. During that time, he launched McKinsey's global drug safety, medical and regulatory service line.

He earned his M.S. and Ph.D. from Duke University in biomedical engineering, with research focused on protein engineering.

"In Dr. Piervincenzi, we have found an outstanding new leader for USP, which has seen unprecedented growth over the past several years," stated Thomas Temple, chairman of the USP Board of Trustees. "I am excited about Dr. Piervincenzi's commitment to the next phase of USP's unique mission to develop and promote cutting-edge global standards for pharmaceuticals, food and dietary supplements."

According to Timothy Franson, president of USP, the appointment of Piervincenzi as CEO brings "an exceptional leader" to the convention. "His ability to motivate people, craft creative solutions to complex problems and the tremendous reputation and respect from his peers are the reasons why Ron was selected," Franson commented. "We are delighted that he has accepted this challenge and are confident that USP is in great hands."

USP noted that, during Williams' tenure as CEO, the convention saw an unprecedented period of growth, undergoing a transformation from being a key standards-setting organization to a recognized leader in global health through the establishment of facilities in Africa, China, India, Brazil and Europe.

In addition, USP said that under the leadership of Williams it embarked on an ambitious effort to create new modernized standards in its compendia and improve access to quality food and drugs. USP is also a key partner with USAID, working to battle the influx of substandard and counterfeit medicines in developing countries and improve lives through enhanced pharmaceutical standards.

"Dr. Williams has had a remarkable tenure," Temple added. "He has transformed this organization in an indelible way and been a driving force in improving public standards, and the organization is grateful for his lasting contributions."

Advertisement